Journalartikel

Impact of Bacterial Toxins in the Lungs


AutorenlisteLucas, Rudolf; Hadizamani, Yalda; Gonzales, Joyce; Gorshkov, Boris; Bodmer, Thomas; Berthiaume, Yves; Moehrlen, Ueli; Lode, Hartmut; Huwer, Hanno; Hudel, Martina; Abu Mraheil, Mobarak; Toque, Haroldo Alfredo Flores; Chakraborty, Trinad; Hamacher, Juerg

Jahr der Veröffentlichung2020

ZeitschriftToxins

Bandnummer12

Heftnummer4

eISSN2072-6651

Open Access StatusGold

DOI Linkhttps://doi.org/10.3390/toxins12040223

VerlagMDPI


Abstract
Bacterial toxins play a key role in the pathogenesis of lung disease. Based on their structural and functional properties, they employ various strategies to modulate lung barrier function and to impair host defense in order to promote infection. Although in general, these toxins target common cellular signaling pathways and host compartments, toxin- and cell-specific effects have also been reported. Toxins can affect resident pulmonary cells involved in alveolar fluid clearance (AFC) and barrier function through impairing vectorial Na+ transport and through cytoskeletal collapse, as such, destroying cell-cell adhesions. The resulting loss of alveolar-capillary barrier integrity and fluid clearance capacity will induce capillary leak and foster edema formation, which will in turn impair gas exchange and endanger the survival of the host. Toxins modulate or neutralize protective host cell mechanisms of both the innate and adaptive immunity response during chronic infection. In particular, toxins can either recruit or kill central players of the lung's innate immune responses to pathogenic attacks, i.e., alveolar macrophages (AMs) and neutrophils. Pulmonary disorders resulting from these toxin actions include, e.g., acute lung injury (ALI), the acute respiratory syndrome (ARDS), and severe pneumonia. When acute infection converts to persistence, i.e., colonization and chronic infection, lung diseases, such as bronchitis, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF) can arise. The aim of this review is to discuss the impact of bacterial toxins in the lungs and the resulting outcomes for pathogenesis, their roles in promoting bacterial dissemination, and bacterial survival in disease progression.



Zitierstile

Harvard-ZitierstilLucas, R., Hadizamani, Y., Gonzales, J., Gorshkov, B., Bodmer, T., Berthiaume, Y., et al. (2020) Impact of Bacterial Toxins in the Lungs, Toxins, 12(4), Article 223. https://doi.org/10.3390/toxins12040223

APA-ZitierstilLucas, R., Hadizamani, Y., Gonzales, J., Gorshkov, B., Bodmer, T., Berthiaume, Y., Moehrlen, U., Lode, H., Huwer, H., Hudel, M., Abu Mraheil, M., Toque, H., Chakraborty, T., & Hamacher, J. (2020). Impact of Bacterial Toxins in the Lungs. Toxins. 12(4), Article 223. https://doi.org/10.3390/toxins12040223



Schlagwörter


ACTIN CYTOSKELETON DISRUPTIONADENYLATE-CYCLASE TOXINAERUGINOSA EXOENZYME-Salveolar-capillary barrieralveolar liquid clearanceANTHRACIS LETHAL TOXINbacterial toxinsBORDETELLA-PERTUSSIS INFECTIONhost defenseMANGANESE SUPEROXIDE-DISMUTASEPANTON-VALENTINE LEUKOCIDINPROTEIN-KINASE-Cpulmonary edemaSTAPHYLOCOCCAL ALPHA-HEMOLYSIN


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 11:11